These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35666752)

  • 41. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.
    Nagashima T; Shimizu K; Matsumoto R; Honda H
    Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye.
    Speier S; Nyqvist D; Köhler M; Caicedo A; Leibiger IB; Berggren PO
    Nat Protoc; 2008; 3(8):1278-86. PubMed ID: 18714296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
    Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
    BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes.
    Takeda M; Ito E; Minami K; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S
    Biochem Biophys Res Commun; 2021 Oct; 574():91-96. PubMed ID: 34450429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.
    Koyanagi-Aoi M; Ohnuki M; Takahashi K; Okita K; Noma H; Sawamura Y; Teramoto I; Narita M; Sato Y; Ichisaka T; Amano N; Watanabe A; Morizane A; Yamada Y; Sato T; Takahashi J; Yamanaka S
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20569-74. PubMed ID: 24259714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells.
    Matsu-ura T; Sasaki H; Okada M; Mikoshiba K; Ashraf M
    Stem Cell Res Ther; 2016 Feb; 7():30. PubMed ID: 26880084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphere-shaped nano-hydroxyapatite/chitosan/gelatin 3D porous scaffolds increase proliferation and osteogenic differentiation of human induced pluripotent stem cells from gingival fibroblasts.
    Ji J; Tong X; Huang X; Wang T; Lin Z; Cao Y; Zhang J; Dong L; Qin H; Hu Q
    Biomed Mater; 2015 Jul; 10(4):045005. PubMed ID: 26154827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Toxicology and Carcinogenesis Studies of Isobutyraldehyde (CAS No. 78-84-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 472():1-242. PubMed ID: 12579201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity.
    Chan SS; Arpke RW; Filareto A; Xie N; Pappas MP; Penaloza JS; Perlingeiro RCR; Kyba M
    Cell Stem Cell; 2018 Jul; 23(1):74-85.e6. PubMed ID: 29979993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity.
    Kuo TC; Chen CT; Baron D; Onder TT; Loewer S; Almeida S; Weismann CM; Xu P; Houghton JM; Gao FB; Daley GQ; Doxsey S
    Nat Cell Biol; 2011 Sep; 13(10):1214-23. PubMed ID: 21909099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells.
    Iida T; Iwanami A; Sanosaka T; Kohyama J; Miyoshi H; Nagoshi N; Kashiwagi R; Toyama Y; Matsumoto M; Nakamura M; Okano H
    Stem Cells; 2017 May; 35(5):1316-1327. PubMed ID: 28142229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas.
    Riegler J; Ebert A; Qin X; Shen Q; Wang M; Ameen M; Kodo K; Ong SG; Lee WH; Lee G; Neofytou E; Gold JD; Connolly AJ; Wu JC
    Stem Cell Reports; 2016 Feb; 6(2):176-87. PubMed ID: 26777057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells.
    Dressel R
    Semin Immunopathol; 2011 Nov; 33(6):573-91. PubMed ID: 21461989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
    Gordeeva OF; Nikonova TM
    Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prospects for use of the anterior chamber of the eye for studying proliferation, differentiation and hybridization of tumor cells].
    Shvemberger IN; Krylenkov VA; Stepan'ian LI; Sanchakova EV; Vakhtin IuB
    Tsitologiia; 1977 Jun; 19(6):665-70. PubMed ID: 197670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
    Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicology and carcinogenesis studies of propargyl alcohol (CAS No. 107-19-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Sep; (552):1-172. PubMed ID: 18974778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumorigenicity studies for human pluripotent stem cell-derived products.
    Kuroda T; Yasuda S; Sato Y
    Biol Pharm Bull; 2013; 36(2):189-92. PubMed ID: 23370350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
    Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.